Analyst Ratings for Zynerba Pharmaceuticals (ZYNE) [Buys]
ZYNE Rating Summary
ZYNE Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.11 (-14.6%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
Avg. $ Target:
$1.11 (-14.6%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/31/2019 | Roth/MKM » Updated 6/30/2020 |
Scott R. Henry | New Coverage | Buy (N/A) |
8.50 (11.00) |
5.64 (1.30) |
-76.95% | Details |
| 9/21/2018 | Cantor Fitzgerald | Charles Duncan | New Coverage | Overweight (N/A) |
21.00 (N/A) |
7.86 (1.30) |
-83.46% | Details |
 |
||||||||
|
||||||||
